Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online:2913
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2015  |  Volume : 14  |  Issue : 2  |  Page : 135-139

Clinicians' awareness on thromboprophylaxis in cancer-associated thrombosis


1 Department of Pathology, Braithwaite Memorial Specialist Hospital, Port Harcourt, Nigeria
2 Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
3 Department of Haematology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

Correspondence Address:
Hannah E Omunakwe
Haematology Unit, Pathology Department, Braithwaite Memorial Specialist Hospital, Port Harcourt, Rivers State
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2384-5589.170187

Rights and Permissions

Context: Venous thromboembolism is a significant cause of morbidity and mortality in cancer patients. Awareness of patients at risk will enable clinicians proffer thromboprophylaxis promptly and thus reduce morbidity and mortality. Aims: The aim of the study is to evaluate the clinicians' awareness and practice of thromboprophylaxis in cancer patients. Materials and Methods: A descriptive questionnaire-based survey of clinicians in the University of Port Harcourt Teaching Hospital. Statistical analysis used: The Statistical analysis was done using SPSS 17.0. Results: Ninety-four clinicians responded (78.33%). Forty (42.55%) could define Venous thromboembolism (VTE) appropriately. Fifty-seven (60.63%) clinicians saw 1-6 cancer patients monthly and majority; 84 (89.36%) said cancer patients were at higher risk of VTE than noncancer patients. The most commonly cited risk factors for cancer-associated thrombosis (CAT) were the site of the tumor (98.9%), surgery (76%), body mass index (76%). Thirty-seven (39.36%) reported offering some form of thromboprophylaxis to their cancer patients. Low molecular weight heparin was most prescribed; by 24 (64.87%) respondents. Fifty-four (57.45%) of the respondents had no idea of the effect of heparins on tumor progression. Conclusions: The awareness of CAT and the importance of thromboprophylaxis amongst our clinicians is low.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2412    
    Printed114    
    Emailed0    
    PDF Downloaded85    
    Comments [Add]    

Recommend this journal